{"entity":{"id":"nct07811037","kind":"trial","name":"A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Efficacy of SGT003 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of SGT003 in advanced solid tumours, run by Beijing Sungen Biomedical Technology Co., Ltd, now recruiting.","summary":"A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Efficacy of SGT003 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07811037 by Beijing Sungen Biomedical Technology Co., Ltd, with 332 participants planned, started 2026-08-17 and due to reach its primary completion in 2028-12. Interventions recorded: SGT003.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07811037","url":"https://clinicaltrials.gov/study/NCT07811037"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07811037","phase":"1/2","setting":"A Multicenter, Dose-Escalation and Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Efficacy of SGT003 in Patients With Advanced Solid Tumors","sponsor":"Beijing Sungen Biomedical Technology Co., Ltd","participation":[{"nct":"NCT07811037","source":"https://clinicaltrials.gov/study/NCT07811037","fetchedAt":"2026-10-07T16:56:52.065Z","studySha256":"34c72ba9d91f2b95dc4d2141612d32cd893fc5a757f2f19e76592c5a7e629049","overallStatus":"RECRUITING","lastUpdatePosted":"2026-09-09","leadSponsor":"Beijing Sungen Biomedical Technology Co., Ltd","collaboratorCount":0,"minimumAge":"18 Years","maximumAge":"75 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":332,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2026-08-17","startedType":"actual","enrolled":332,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07811037/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}